Your browser doesn't support javascript.
loading
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease.
Fuzzati-Armentero, Marie-Therese; Cerri, Silvia; Levandis, Giovanna; Ambrosi, Giulia; Montepeloso, Elena; Antoninetti, Gianfilippo; Blandini, Fabio; Baqi, Younis; Müller, Christa E; Volpini, Rosaria; Costa, Giulia; Simola, Nicola; Pinna, Annalisa.
Afiliação
  • Fuzzati-Armentero MT; Laboratory of Functional Neurochemistry, Center for Research In Neurodegenerative Diseases C. Mondino National Neurological Institute, Pavia, Italy.
  • Cerri S; Laboratory of Functional Neurochemistry, Center for Research In Neurodegenerative Diseases C. Mondino National Neurological Institute, Pavia, Italy.
  • Levandis G; Laboratory of Functional Neurochemistry, Center for Research In Neurodegenerative Diseases C. Mondino National Neurological Institute, Pavia, Italy.
  • Ambrosi G; Laboratory of Functional Neurochemistry, Center for Research In Neurodegenerative Diseases C. Mondino National Neurological Institute, Pavia, Italy.
  • Montepeloso E; Laboratory of Functional Neurochemistry, Center for Research In Neurodegenerative Diseases C. Mondino National Neurological Institute, Pavia, Italy.
  • Antoninetti G; Laboratory of Functional Neurochemistry, Center for Research In Neurodegenerative Diseases C. Mondino National Neurological Institute, Pavia, Italy.
  • Blandini F; Laboratory of Functional Neurochemistry, Center for Research In Neurodegenerative Diseases C. Mondino National Neurological Institute, Pavia, Italy.
  • Baqi Y; Pharmaceutical Institute, Pharmaceutical Chemistry I, Pharma Center Bonn, University of Bonn, Bonn, Germany.
  • Müller CE; Department of Chemistry, Faculty of Science, Sultan Qaboos University, Muscat, Oman.
  • Volpini R; Pharmaceutical Institute, Pharmaceutical Chemistry I, Pharma Center Bonn, University of Bonn, Bonn, Germany.
  • Costa G; School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, Camerino, Italy.
  • Simola N; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Pinna A; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
J Neurochem ; 134(4): 740-7, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25962878
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Levodopa / Fármacos Neuroprotetores / Transtornos Parkinsonianos / Antagonistas de Receptores Purinérgicos P1 / Receptor de Glutamato Metabotrópico 5 / Neurônios Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Levodopa / Fármacos Neuroprotetores / Transtornos Parkinsonianos / Antagonistas de Receptores Purinérgicos P1 / Receptor de Glutamato Metabotrópico 5 / Neurônios Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article